Research Project

Project Title:

A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant

Project Type:

Clinical Trial, Enrolment ongoing

Disease group(s):

Pediatric kidney transplantation

Project Summary:

The purpose of this study is to evaluate the reactogenicity, safety and immunogenicity of 2 doses of PED-HZ/su, GSK's vaccine candidate for the prevention of Herpes Zoster (HZ) in immunocompromised paediatric renal transplant recipients aged 1-17 years

Lead principal investigator(s):

Giovanni Montini, Milan

Co-investigator(s):

Sara Testa, Milan
Gema Ariceta, Barcelona

Project Period:

10/2019   -   02/2025

Sponsors:

Industry

ClinicalTrials.gov:

NCT04006808

EudraCT Nr.:

2019-000607-33

« Back to research page